Dr Sarah-Jane Schramm

Postdoctoral Research Associate
Medicine, Westmead Clinical School

W: Related website
Related website

Biographical details

Research interests

Molecular biomarkers of melanoma progression and prognosis

Cancer systems biology

Network biology

Integrative -omics


Network visualisation

Please check out my (more or less) fortnightly blog:The Inside Voice – reflections and ramblings of a newly minted post-doc. You can find it on the Sydney West Translational Cancer Research Centre knowledge portal.


Bioinformatics; Systems Biology; Melanoma; Integrative -omics


2015 | 2014 | 2013 | 2012 | 2011


  • Jayawardana, K., Schramm, S., Haydu, L., Thompson, J., Scolyer, R., Mann, G., Müller, S., Yang, J. (2015), Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information. International Journal of Cancer. 136(4), 863-874. [Abstract]


  • Barter, R., Schramm, S., Mann, G., Yang, Y. (2014), Network-based biomarkers enhance classical approaches to prognostic gene expression signatures. BMC Systems Biology. 8 Suppl 4, S5. [Abstract]


  • Schramm, S., Menzies, A., Mann, G. (2013), Molecular biomarkers of prognosis in melanoma: how far are we from the clinic?. Melanoma Research. 23, 423-425. [Abstract]
  • Schramm, S., Jayaswal, V., Goel, A., Li, S., Yang, Y., Mann, G., Wilkins, M. (2013), Molecular interaction networks for the analysis of human disease: utility, limitations, and considerations. Proteomics. 13(23-24), 3393-3405. [Abstract]
  • Mann, G., Pupo, G., Campain, A., Carter, C., Schramm, S., Pianova, S., Gerega, S., De Silva, C., Lai, K., Wilmott, J., Synnott, M., Hersey, P., Kefford, R., Thompson, J., Yang, Y., Scolyer, R. (2013), BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma. The Journal of Investigative Dermatology. 133(2), 509-517. [Abstract]
  • Schramm, S., Li, S., Jayaswal, V., Fung, D., Campain, A., Pang, C., Scolyer, R., Yang, Y., Mann, G., Wilkins, M. (2013), Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden. Pigment Cell & Melanoma Research. 26, 708-722. [Abstract]
  • Jayaswal, V., Schramm, S., Mann, G., Wilkins, M., Yang, Y. (2013), VAN: an R package for identifying biologically perturbed networks via differential variability analysis. BMC Research Notes. 6(1), 430. [Abstract]


  • Schramm, S., Campain, A., Scolyer, R., Yang, Y., Mann, G. (2012), Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis. The Journal of investigative dermatology. 132(2), 274-83. [Abstract]


  • Schramm, S., Mann, G. (2011), Melanoma Prognosis: A REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies. Molecular cancer therapeutics. 10(8), 1520-8. [Abstract]